Organogenesis Holdings Inc.ORGONASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank89
3Y CAGR+18.2%
5Y CAGR+6.1%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+18.2%/yr
Annual compound
5Y CAGR
+6.1%/yr
Recent acceleration
Percentile
P89
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
202514.77%+351.7%
20243.27%-60.7%
20238.32%-7.0%
20228.94%-52.0%
202118.61%+69.2%
202011.00%+245.5%
2019-7.56%+68.8%
2018-24.25%-
20170.00%-
20160.00%-